Inventor · disambiguated record
Keith Demarest
Also filed as: DEMAREST KEITH · DEMAREST KEITH T
30 granted patents·14 pending applications·403 citations·filing 1991–2017
96Inventor score
Files withJANSSEN PHARMACEUTICA NV18ORTHO MCNEIL PHARM INC3BUSSOLARI JACQUELINE C2CHEN XIAOLI2HEINTZELMAN GEOFFREY R2
Top patents by PatentIndex Score
44 records- 0196US6987110B2Substituted pyrrolines as kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Jan 17, 2006·107 cites·29 claims
- 0296US6653478B2Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide Y modulatorsORTHO MCNEIL PHARM INC·Filed 2001·Granted Nov 25, 2003·73 cites·23 claims
- 0392US7750048B2GPR40 agonistsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Jul 6, 2010·15 cites·17 claims
- 0492US7425649B24-((phenoxyalkyl)thio)-phenoxyacetic acids and analogsJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Sep 16, 2008·20 cites·40 claims
- 0591US7125878B2Substituted pyrroline kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Oct 24, 2006·33 cites·26 claims
- 0690US7598416B24-((phenoxyalkyl)thio)-phenoxyacetic acids and analogsJANSSEN PHARMACEUTICA NV·Filed 2008·Granted Oct 6, 2009·12 cites·18 claims
- 0784US7678786B2Benzoazepin-oxy-acetic acid derivatives as PPAR-delta agonists used for the increase of HDL-C, lower LDL-C and lower cholesterolJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Mar 16, 2010·8 cites·24 claims
- 0882US6903109B2Arylindenopyridines and related therapeutic and prophylactic methodsORTHO MUNIEL PHARMACEUTICAL IN·Filed 2002·Granted Jun 7, 2005·19 cites·24 claims
- 0982US6828327B2Macroheterocylic compounds useful as kinase inhibitorsORTHO MCNEIL PHARM INC·Filed 2001·Granted Dec 7, 2004·18 cites·5 claims
- 1081US7928238B21,2,3,4-tetrahydro-quinoline derivatives as CETP inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Apr 19, 2011·7 cites·57 claims
- 1181US5532226ATrifluoromethybenzylphosphonates useful in treating osteoporosisORTHO PHARMA CORP·Filed 1993·Granted Jul 2, 1996·35 cites·12 claims
- 1280US7232906B2Substituted pyrrolines as kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Jun 19, 2007·11 cites·31 claims
- 1379US7781450B2Substituted pyrroline kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2009·Granted Aug 24, 2010·2 cites·30 claims
- 1478US7786135B2Substituted pyrroline kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Aug 31, 2010·2 cites·7 claims
- 1578US6838442B2Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulatorsORTHO MCNEIL PHARM INC·Filed 2002·Granted Jan 4, 2005·12 cites·33 claims
- 1677US7351857B2Methods of using substituted tetralins and indanesJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Apr 1, 2008·3 cites·43 claims
- 1773US7608634B2Substituted pyrrolines as kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Oct 27, 2009·1 cites·10 claims
- 1872US5300687ATrifluoromethylbenzylphosphonates useful in treating osteoporosisORTHO PHARMA CORP·Filed 1991·Granted Apr 5, 1994·22 cites·2 claims
- 1969US7825110B2Substituted spiroheterocyclesJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Nov 2, 2010·1 cites·25 claims
- 2068US10195178B2GPR40 agonists in anti-diabetic drug combinationsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Feb 5, 2019·1 cites·33 claims
- 2166US7875744B24-((phenoxyalkyl)thio)-phenoxyacetic acids and analogsJANSSEN PHARMACEUTICA NV·Filed 2009·Granted Jan 25, 2011·0 cites·20 claims
- 2263US8242173B24-((phenoxyalkyl)thio)-phenoxyacetic acids and analogsDEANGELIS ALAN·Filed 2010·Granted Aug 14, 2012·1 cites·14 claims
- 2356US7749995B23,4-dihydro-2h-benzo[1,4]oxazine and thiazine derivatives as CETP inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Jul 6, 2010·0 cites·49 claims
- 2455US2006154949A1Arylindenopyridines and related therapeutic and prophylactic methodsHEINTZELMAN GEOFFREY R·Filed 2005·Application pending·0 cites
- 2554US8278268B2Combination therapy comprising glucose reabsorption inhibitors and PPAR modulatorsBUSSOLARI JACQUELINE C·Filed 2007·Granted Oct 2, 2012·0 cites·29 claims
- 2652US8183213B2Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulatorsBUSSOLARI JACQUELINE C·Filed 2007·Granted May 22, 2012·0 cites·5 claims
- 2751US2007219245A1Method of use for substituted dipiperidine ccr2 antagonistsHOU CUIFEN·Filed 2007·Application pending·0 cites
- 2850US2004167211A1Methods of using substituted tetralins and indanesFiled 2003·Application pending·0 cites
- 2950US2004171680A1Treating Syndrome X with substituted tetralins and indanesFiled 2003·Application pending·0 cites
- 3049US2004162352A1Treating syndrome X with substituted tetralins and indanesFiled 2003·Application pending·0 cites
- 3149US2003199557A1Combination therapy comprising glucose reabsorption inhibitors and PPAR modulatorsFiled 2003·Application pending·0 cites
- 3247US7825111B2Substituted spiroheterocyclesJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Nov 2, 2010·0 cites·26 claims
- 3347US7812053B24-((phenoxyalkyl)thio)-phenoxyacetic acids and analogsJANSSEN PHARMACEUTICALS NV·Filed 2005·Granted Oct 12, 2010·0 cites·49 claims
- 3447US2003195235A1Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulatorsFiled 2003·Application pending·0 cites
- 3545US8012963B23,4-dihydro-2H-benzo[1,4]oxazine and thiazine derivatives as CETP inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2010·Granted Sep 6, 2011·0 cites·25 claims
- 3645US2003045553A1Combination therapy comprising glucose reabsorption inhibitors and PPAR modulatorsFiled 2002·Application pending·0 cites
- 3745US2010240650A1Substituted pyrrolines as kinase inhibitorsZHANG HAN-CHENG·Filed 2010·Application pending·0 cites
- 3843US8633184B2Benzoazepin-oxy-acetic acid derivatives as PPAR-delta agonists used for the increase of HDL-C, lower LDL-C and lower cholesterolKUO GEE-HONG·Filed 2010·Granted Jan 21, 2014·0 cites·10 claims
- 3943US2007197590A1Substituted dipiperidine ccr2 antagonistsDEMONG DUANE E·Filed 2007·Application pending·0 cites
- 4042US2005239782A1Arylindenopyridines and related therapeutic and prophylactic methodsHEINTZELMAN GEOFFREY R·Filed 2005·Application pending·0 cites
- 4139US2005191668A1Methods of using peroxisome proliferator-activated receptor alpha target genesFiled 2005·Application pending·0 cites
- 4238US2006247314A1Substituted tetralins and indanesCHEN XIAOLI·Filed 2005·Application pending·0 cites
- 4338US2006094786A1Treating syndrome X with substituted tetralins and indanesCHEN XIAOLI·Filed 2005·Application pending·0 cites
- 4430US8147801B2Methods of using alpha-methylglucoside (AMG) as an indicator for glucose absorption and excretionDEMAREST KEITH T·Filed 2010·Granted Apr 3, 2012·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Keith Demarest files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →